Updates on the Molecular Genetics of Colorectal Cancer
Journal Title: Colorectal Cancer: Open Access - Year 2017, Vol 3, Issue 1
Abstract
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Although definitive therapies for advanced disease are still lacking, rapid progress has been made in the last decade in understanding the molecular mechanisms underlying CRC tumorigenesis and progression. In this review, we summarize the most recent findings in the molecular genetics of CRC with a focus on gene mutations and epigenetic changes that were identified in CRC patients.
Authors and Affiliations
Katherine Wong, Guofeng Xie
Keywords
Related Articles
- EP ID EP311169
- DOI 10.21767/2471-9943.100032
- Views 124
- Downloads 0
Second Gastric Cancer After the Treatment of Primary Stomach Diffuse Large B-Cell Lymphoma
We report a case of gastric carcinoma occurred 11 years after treatment of gastric lymphoma in a 38-year-old patient with a review of the literature.
Incidence and Clinical Characteristics of Colonic and Extra Colonic Lynch Syndrome Manifestations in Uruguayan Mismatch Repair Carriers
Background: Colon cancer is a frequent diagnosis worldwide affecting both men and women. Lynch syndrome in an autosomal dominant inheritable condition, accountable for 5 to 7% of colon cancer, as well as other malignanci...
Screening is the Most Effective Preventive Measure against Colorectal Cancer
According to the American Cancer Society, an estimated 135,430 people will be diagnosed with colon cancer in 2017 alone. There’s no denying how much of a problem colorectal cancer has become, but what many people don’t r...
Colic Adenocarcinoma Revealed by Ileo-Colic Intussusception
Introduction: Intussusception is unusual in adults; it accounts for 5% of intestinal occlusions at this age. It is most often secondary to a benign or malignant organic lesion. Result: Through this observation, we repor...
CDX2 - A Predictive Biomarker in Stage II Colon Cancer for Adjuvant Chemotherapy?
In the United States, colorectal cancer (CRC) is the third most common cancer among men and women. Estimated new cases were 134,490 in 2016, which was 8% of all new cancer cases, while 49,190 deaths were expected [1]. Th...